Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Kahwaji

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Transplantation|July 16, 2014
The authors' replyJoseph Kahwaji, Stanley Jordan, Dechu Puliyanda, et al.
Expert Review of Clinical Immunology|October 29, 2010
ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?Joseph Kahwaji, Ashley A Vo, Stanley C Jordan
Kidney360|January 23, 2025
Safety and Efficacy of Liraglutide and Semaglutide in Kidney Transplant RecipientsJoseph Kahwaji, Sean Hashmi, Chong Young Parke, et al.
World Journal of Nephrology|July 14, 2015
Modern approaches to incompatible kidney transplantationPatarapha Wongsaroj, Joseph Kahwaji, Ashley Vo, et al.
Current Opinion in Organ Transplantation|June 14, 2011
B-cell immunotherapeutics: emerging roles in solid organ transplantationStanley C Jordan, Joseph Kahwaji, Mieko Toyoda, et al.
Clinical Transplants|May 18, 2017
Immunologic and Infectious Complications in Highly Sensitized Patients Post-Kidney TransplantationJoseph Kahwaji, Jua Choi, Ashley Vo, et al.
Transplantation|November 5, 2010
Cause of death with graft function among renal transplant recipients in an integrated healthcare systemJoseph Kahwaji, Suphamai Bunnapradist, Jin-Wen Hsu, et al.
Rhinology|May 16, 2002
Low grade primary clear cell carcinoma of the sinonasal tractUsamah Moh'd Hadi, Ghassan Joseph Kahwaji, Amjad Afif Mufarrij, et al.
Current Opinion in Organ Transplantation|June 4, 2016
Risk factors associated with the development of histocompatibility leukocyte antigen sensitizationStanley C Jordan, Jua Choi, Irene Kim, et al.
Clinical Transplantation|March 4, 2014
Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximabJoseph Kahwaji, Reiad Najjar, Deepika Kancherla, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Transplantation|July 16, 2014
The authors' replyJoseph Kahwaji, Stanley Jordan, Dechu Puliyanda, et al.
Expert Review of Clinical Immunology|October 29, 2010
ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?Joseph Kahwaji, Ashley A Vo, Stanley C Jordan
Kidney360|January 23, 2025
Safety and Efficacy of Liraglutide and Semaglutide in Kidney Transplant RecipientsJoseph Kahwaji, Sean Hashmi, Chong Young Parke, et al.
World Journal of Nephrology|July 14, 2015
Modern approaches to incompatible kidney transplantationPatarapha Wongsaroj, Joseph Kahwaji, Ashley Vo, et al.
Current Opinion in Organ Transplantation|June 14, 2011
B-cell immunotherapeutics: emerging roles in solid organ transplantationStanley C Jordan, Joseph Kahwaji, Mieko Toyoda, et al.
Clinical Transplants|May 18, 2017
Immunologic and Infectious Complications in Highly Sensitized Patients Post-Kidney TransplantationJoseph Kahwaji, Jua Choi, Ashley Vo, et al.
Transplantation|November 5, 2010
Cause of death with graft function among renal transplant recipients in an integrated healthcare systemJoseph Kahwaji, Suphamai Bunnapradist, Jin-Wen Hsu, et al.
Rhinology|May 16, 2002
Low grade primary clear cell carcinoma of the sinonasal tractUsamah Moh'd Hadi, Ghassan Joseph Kahwaji, Amjad Afif Mufarrij, et al.
Current Opinion in Organ Transplantation|June 4, 2016
Risk factors associated with the development of histocompatibility leukocyte antigen sensitizationStanley C Jordan, Jua Choi, Irene Kim, et al.
Clinical Transplantation|March 4, 2014
Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximabJoseph Kahwaji, Reiad Najjar, Deepika Kancherla, et al.
Pageof 3